• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table F-75-year relative survival by age and race for ovarian cancer

Race and AgePercent Surviving at End of Interval
White
AgeNumber at Start of Followup1 year2 years3 years4 years5 years
0-44110693.90%87.80%83.30%79.50%74.40%
45-45180591.00%80.80%71.60%65.00%59.20%
55-64219786.10%73.70%61.70%52.50%46.10%
65-74182976.00%60.90%50.40%41.70%34.00%
75+25681.00%1.20%1.30%1.40%1.50%
Black
Age
0-4417150.80%38.70%31.60%25.60%21.70%
45-4519587.20%77.70%69.70%66.30%62.90%
55-6420776.90%62.80%52.60%44.70%38.60%
65-7417467.90%55.70%41.20%38.20%33.10%
75+16940.80%30.40%22.20%15.20%14.40%

From: Appendix F, Model Description and Parameters

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.